1. Chronic Parkinsonism in humans due to a product of meperidin-analog synthesis;Langston;Science,1983
2. MPTP in animal models of Parkinson's disease;Kopin;Mt Sinai J Med (NY),1988
3. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropiridine oxidase inhibitors;Heikkila;Nature,1984
4. (−)-Deprenyl combined with L-dopa in the treatment of Parkinson's disease;Elizan,1993
5. Some puzzling pharmacological effects of monoamine oxidase inhibitors;Knoll;Adv Biochem Psychopharmacol,1972